FDA approves Serenity Pharmaceuticals’ Noctiva for nocturnal polyuria

Serenity Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for Noctiva (desmopressin acetate), a nasal spray developed to treat nocturnal polyuria syndrome in ... Read More